[Tyr0]-Hypercalcemia Malignancy Factor (1-40) is a tyrosine-extended analog of a PTH-related peptide region, designed for enhanced detection and conjugation. The added residue provides a chromophoric handle without disrupting the main regulatory domain. Its structure supports investigations of PTH-related protein signaling. Researchers employ it in receptor-binding and peptide trafficking studies.
CAT No: P03044
1. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
2. Myotropic activity of allatostatins in tenebrionid beetles
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More